Heterologous Boost Immunization with an Aerosolised Ad5-nCoV After Two-dose Priming with an Inactivated SARS-CoV-2 Vaccine
Clinical trial NCT05204589 · COMPLETED
Trial details
- NCT number
- NCT05204589
- Sponsor
- Jiangsu Province Centers for Disease Control and Prevention
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-01-22
- Primary completion
- 2022-04-01
- Enrollment
- 10285
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.